Safety Assessment of the CP4 EPSPS and NPTII Proteins in Eucalyptus.

CP4-EPSPS eucalyptus genetically modified glyphosate-tolerance saftey assesments

Journal

GM crops & food
ISSN: 2164-5701
Titre abrégé: GM Crops Food
Pays: United States
ID NLM: 101572655

Informations de publication

Date de publication:
31 Dec 2023
Historique:
medline: 21 6 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: ppublish

Résumé

Glyphosate herbicide treatment is essential to sustainable Eucalyptus plantation management in Brazil. Eucalyptus is highly sensitive to glyphosate, and Suzano/FuturaGene has genetically modified eucalyptus to tolerate glyphosate, with the aim of both protecting eucalyptus trees from glyphosate application damage and improving weed management. This study presents the biosafety results of the glyphosate-tolerant eucalyptus event 751K032, which expresses the selection marker neomycin phosphotransferase II (NPTII) enzyme and CP4-EPSPS, a glyphosate-tolerant variant of plant 5-enolpyruvyl-shikimate-3-phosphate synthase enzyme. The transgenic genetically modified (GM) event 751K032 behaved in the plantations like conventional non-transgenic eucalyptus clone, FGN-K, and had no effects on arthropods and soil microorganisms. The engineered NPTII and CP4 EPSPS proteins were heat-labile, readily digestible, and according to the bioinformatics analyses, unlikely to cause an allergenic or toxic reaction in humans or animals. This assessment of the biosafety of the glyphosate-tolerant eucalyptus event 751K032 concludes that it is safe to be used for wood production.

Identifiants

pubmed: 37334790
doi: 10.1080/21645698.2023.2222436
pmc: PMC10281460
doi:

Substances chimiques

Kanamycin Kinase EC 2.7.1.95
shikimate 0
Herbicides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Références

Protein Sci. 2006 Jan;15(1):182-9
pubmed: 16322573
EFSA J. 2019 Aug 08;17(8):e05774
pubmed: 32626404
Methods Mol Biol. 2000;132:185-219
pubmed: 10547837
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
J Nutr. 1996 Mar;126(3):728-40
pubmed: 8598558
Biochemistry. 2007 May 8;46(18):5570-8
pubmed: 17425289
Methods Enzymol. 1990;183:63-98
pubmed: 2156132
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Gene. 1982 Oct;19(3):327-36
pubmed: 6295884
Transgenic Res. 2018 Dec;27(6):511-524
pubmed: 30173346
J Insect Sci. 2011;11:28
pubmed: 21529148
Food Chem Toxicol. 2008 Oct;46 Suppl 10:S20-3
pubmed: 18708115
Regul Toxicol Pharmacol. 2004 Apr;39(2):87-98
pubmed: 15041142
Sci Total Environ. 2008 Aug 1;400(1-3):356-68
pubmed: 18657304
J Agric Food Chem. 2002 Nov 20;50(24):7154-60
pubmed: 12428975
Methods Mol Biol. 2019;1864:313-342
pubmed: 30415345
Brief Bioinform. 2021 Jan 18;22(1):178-193
pubmed: 31848574
Transgenic Res. 2023 Jun;32(3):179-191
pubmed: 37029291
Biotechnology (N Y). 1993 Dec;11(13):1543-7
pubmed: 7764244
Pest Manag Sci. 2014 Sep;70(9):1367-77
pubmed: 25180399

Auteurs

Dror Avisar (D)

R&D, FuturaGene Israel Ltd, Rehovot, Israel.

Shelly Azulay (S)

R&D, FuturaGene Israel Ltd, Rehovot, Israel.

Lorena Bombonato (L)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Denise Carvalho (D)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Heitor Dallapicolla (H)

Suzano S.A. (Forest Management), SP, Brazil.

Carla de Souza (C)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Anselmo Dos Santos (A)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Tatiane Dias (T)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Maria Paula Galan (MP)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Milton Galvao (M)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

José Mateus Gonsalves (JM)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Esteban Gonzales (E)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Rodrigo Graça (R)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Sivan Livne (S)

R&D, FuturaGene Israel Ltd, Rehovot, Israel.

Reginaldo Mafia (R)

Suzano S.A. (Forest Management), SP, Brazil.

Alexandre Manoeli (A)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Mike May (M)

R&D, FuturaGene Israel Ltd, Rehovot, Israel.

Thaís Regina Drezza Menezes (TRD)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Ana Cristina Pinheiro (AC)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Antonio Porto (A)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Carolina Rocha (C)

Suzano S.A. (FuturaGene - Biotech Division), Itapetininga, Brazil.

Ariane Schafer (A)

Schafer Scientific Solutions LLC, Indianapolis, USA.

Barry Schafer (B)

Schafer Scientific Solutions LLC, Indianapolis, USA.

Edival Zauza (E)

Suzano S.A. (Forest Management), SP, Brazil.

William Silva (W)

W J Silva Consultoria Agricola S/C LTDA, Jardinópolis, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH